Neuromuscular Junction Disorders — MCQs
Which of the following is true regarding weakness in myasthenia gravis?
Myasthenia gravis is a disorder of:
Lambert-Eaton Myasthenic Syndrome is associated with?
Which of the following is a typical clinical feature of Lambert-Eaton myasthenic syndrome?
A 25-year-old woman presents with symptoms of fatigue and weakness. On examination, there is diplopia, ptosis, weakness, and fatigability of muscles on repeated use. Which of the following is the most likely diagnosis?
A 26-year-old woman complains of early fatigue and weakness in doing strenuous activity. Her symptoms are worse near the end of the day. She appears well, muscle bulk, tone, and reflexes are normal. Handgrip strength decreases with repetitive testing.For the above patient with muscle weakness, select the most likely anatomic site for the disorder
A 35-year-old female presents with progressive muscle weakness. EMG shows decremental response. What is the diagnosis?
21-year-old female presents with history of mild bilateral ptosis, proximal muscle weakness, and easy fatiguability. Which among the following is best in diagnosing this condition?
The electromyogram (EMG) is least useful for the diagnosis of:
Cobra poison is:
Neuromuscular Junction Disorders Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following is true regarding weakness in myasthenia gravis?
- A. Deep tendon reflexes are lost
- B. Only skeletal muscles are involved (Correct Answer)
- C. Associated with sensory loss
- D. Associated with some degree of altered sensorium
Explanation: ***Only skeletal muscles are involved*** - Myasthenia gravis is an **autoimmune disease** that primarily affects the **neuromuscular junction** of **skeletal muscles** [1], [2]. - This leads to **muscle weakness** and fatigue, but does not typically involve smooth or cardiac muscle. *Deep tendon reflexes are lost* - **Deep tendon reflexes** are typically **preserved** in myasthenia gravis, even in the presence of severe muscle weakness [3]. - The disease affects the transmission of impulses at the motor end plate, not the reflex arc itself. *Associated with sensory loss* - Myasthenia gravis is a **purely motor disorder** and does **not involve sensory nerves**. - Patients will experience muscle weakness but maintain normal sensation. *Associated with some degree of altered sensorium* - Myasthenia gravis does **not directly affect the central nervous system** or cause altered consciousness. - Any altered sensorium would suggest a different or coexisting neurological condition.
Question 2: Myasthenia gravis is a disorder of:
- A. Spinal cord
- B. Motor neuron
- C. Neuromuscular junction (Correct Answer)
- D. Peripheral nerve
Explanation: Neuromuscular junction - **Myasthenia gravis** is an **autoimmune disorder** where antibodies attack **acetylcholine receptors** at the **neuromuscular junction**, impairing nerve-to-muscle communication [1], [2]. - This leads to characteristic **muscle weakness** that worsens with activity and improves with rest [2]. *Spinal cord* - Disorders of the **spinal cord** typically involve sensory, motor, and autonomic deficits below the level of the lesion, often characterized by **spasticity** and **hyperreflexia**. - **Myasthenia gravis** does not directly affect the spinal cord, and its symptoms are distinct from spinal cord pathologies. *Motor neuron* - **Motor neuron diseases** (e.g., **ALS**) primarily affect the motor neurons in the brain and spinal cord, leading to progressive **muscle atrophy**, **fasciculations**, and **weakness** due to **denervation**. - Myasthenia gravis does not involve motor neuron degeneration; the neurons themselves are healthy. *Peripheral nerve* - **Peripheral nerve disorders** (e.g., **Guillain-Barré syndrome**) involve damage to nerves outside the brain and spinal cord, causing sensory changes (numbness, tingling), muscle weakness, and often **diminished reflexes**. - While myasthenia gravis causes weakness, it is due to a problem at the junction between the nerve and muscle, not within the nerve itself.
Question 3: Lambert-Eaton Myasthenic Syndrome is associated with?
- A. Vitiligo
- B. Hyperthyroidism
- C. Small cell lung carcinoma (Correct Answer)
- D. All of the options
Explanation: ***Small cell lung carcinoma*** - **Lambert-Eaton Myasthenic Syndrome (LEMS)** is a paraneoplastic syndrome, most commonly associated with **small cell lung carcinoma (SCLC)** [1], [2]. - SCLC cells express **voltage-gated calcium channels** that are targeted by autoantibodies in LEMS, leading to impaired acetylcholine release [1]. *Vitiligo* - **Vitiligo** is an autoimmune skin condition causing depigmentation and is generally associated with other autoimmune diseases, not LEMS. - While both LEMS and vitiligo can involve immune dysregulation, there is no direct and common association between the two. *Hyperthyroidism* - **Hyperthyroidism**, particularly due to Graves' disease, is an autoimmune condition primarily affecting the thyroid gland. - It is not a known direct or common association with LEMS. Myasthenia gravis, however, can be associated with hyperthyroidism. *All of the options* - While LEMS is an autoimmune disorder, its primary and most significant association is with **small cell lung carcinoma** [1], [3]. - The other conditions listed (vitiligo, hyperthyroidism) are not directly or commonly linked to LEMS.
Question 4: Which of the following is a typical clinical feature of Lambert-Eaton myasthenic syndrome?
- A. Improvement of strength with exercise (Correct Answer)
- B. Ptosis and diplopia
- C. Proximal muscle weakness
- D. Decreased deep tendon reflexes
Explanation: ***Improvement of strength with exercise*** - A hallmark clinical feature of **Lambert-Eaton myasthenic syndrome (LEMS)** is the **post-tetanic potentiation**, where brief, repetitive muscle contractions (exercise) temporarily improve muscle strength [2]. - This transient improvement is due to the **cumulative effect of acetylcholine (ACh) release** at the neuromuscular junction with repeated stimulation [3]. *Proximal muscle weakness* - While **proximal muscle weakness** is a common symptom in LEMS, it is not a *typical clinical feature* that distinguishes it from other neuromuscular disorders like myasthenia gravis, where proximal weakness is also prominent. - The *pattern* of weakness is similar to myasthenia gravis, but the *response to exercise* is a key differentiator [2]. *Decreased deep tendon reflexes* - **Decreased or absent deep tendon reflexes (DTRs)** are characteristic findings in LEMS, often accompanied by **autonomic symptoms** [2]. - This is a significant diagnostic clue but not the sole defining characteristic like the **improvement with exercise**. *Ptosis and diplopia* - **Ptosis (drooping eyelids)** and **diplopia (double vision)** are classic symptoms of **myasthenia gravis**, an autoimmune disorder affecting the neuromuscular junction [1]. - While some cranial nerve involvement can occur in LEMS, these ocular symptoms are far less prominent and severe compared to myasthenia gravis.
Question 5: A 25-year-old woman presents with symptoms of fatigue and weakness. On examination, there is diplopia, ptosis, weakness, and fatigability of muscles on repeated use. Which of the following is the most likely diagnosis?
- A. multiple sclerosis
- B. muscular dystrophy
- C. TIAs
- D. myasthenia gravis (Correct Answer)
Explanation: ***myasthenia gravis*** - **Diplopia**, **ptosis**, and **fatigability of muscles with repeated use** are classic symptoms of myasthenia gravis, an autoimmune disorder affecting the neuromuscular junction [1]. - The symptoms are often worse at the end of the day or after exercise due to a decrease in acetylcholine receptors [2]. *multiple sclerosis* - While MS can cause diplopia and fatigue, muscle weakness in MS is typically spastic rather than fatigable and often presents with other neurological deficits such as sensory disturbances or ataxia. - Ptosis is not a common presenting symptom of multiple sclerosis. *muscular dystrophy* - Muscular dystrophies are characterized by progressive muscle weakness and degeneration, but they typically do not present with the hallmark fatigability on repeated use or fluctuating symptoms seen in myasthenia gravis. - Diplopia and ptosis are not typical initial or prominent features of most muscular dystrophies. *TIAs* - Transient ischemic attacks (TIAs) are brief episodes of neurological dysfunction caused by temporary focal cerebral or retinal ischemia, characterized by sudden onset and rapid resolution (usually within minutes to an hour). - The presented symptoms of fatigability and fluctuating weakness over time are not consistent with the acute, short-lived nature of a TIA.
Question 6: A 26-year-old woman complains of early fatigue and weakness in doing strenuous activity. Her symptoms are worse near the end of the day. She appears well, muscle bulk, tone, and reflexes are normal. Handgrip strength decreases with repetitive testing.For the above patient with muscle weakness, select the most likely anatomic site for the disorder
- A. muscle
- B. neuromuscular junction (Correct Answer)
- C. peripheral nerve
- D. anterior horn cell
Explanation: ***neuromuscular junction*** - The **fatigability** and **end-of-day worsening** of weakness, along with the **decreased handgrip strength with repetitive testing**, are classic signs of **myasthenia gravis**, a disorder of the neuromuscular junction [1], [2]. - In myasthenia gravis, **acetylcholine receptor antibodies** block or destroy receptors at the neuromuscular junction, impairing nerve-to-muscle signal transmission [3]. *muscle* - Primary muscle disorders (myopathies) typically present with **proximal muscle weakness** but do not usually show the characteristic **fatigability with repetitive use** or end-of-day worsening. - Muscle bulk, tone, and reflexes would often be affected in significant primary muscle disease. *peripheral nerve* - Peripheral nerve disorders (neuropathies) usually cause **sensory changes** (tingling, numbness) along with motor weakness, and often present with **diminished reflexes**. - The distinguishing feature of **fatigability with repetitive testing** is not typical of peripheral neuropathies. *anterior horn cell* - Anterior horn cell disorders, such as **amyotrophic lateral sclerosis (ALS)**, cause progressive weakness, muscle atrophy, and fasciculations. - While they cause weakness, they typically do not exhibit the significant **day-to-day fluctuation** or **fatigability with repetitive use** described.
Question 7: A 35-year-old female presents with progressive muscle weakness. EMG shows decremental response. What is the diagnosis?
- A. Multiple sclerosis
- B. ALS
- C. Guillain-Barré
- D. Myasthenia gravis (Correct Answer)
Explanation: ***Myasthenia gravis*** - **Myasthenia gravis** is characterized by **autoantibodies** against **acetylcholine receptors (AChRs)** at the neuromuscular junction, leading to muscle weakness that worsens with repetition [1]. - An **EMG showing a decremental response with repetitive nerve stimulation** is a classic diagnostic finding, indicating impaired neuromuscular transmission [2]. *Multiple sclerosis* - **Multiple sclerosis** is a **demyelinating disease** of the central nervous system, and its EMG findings would typically show evidence of demyelination or axonal loss within the central pathways, not a neuromuscular junction defect. - While it causes progressive weakness, the mechanism and characteristic EMG findings (e.g., **evoked potentials** abnormalities) differ significantly from myasthenia gravis [2]. *ALS* - **Amyotrophic lateral sclerosis (ALS)** is a **motor neuron disease** characterized by degeneration of both upper and lower motor neurons, causing progressive weakness and muscle atrophy. - EMG in ALS typically shows widespread signs of **denervation** and **reinnervation** (e.g., fibrillation potentials, fasciculations, giant motor unit potentials), not a decremental response with repetitive stimulation indicative of a neuromuscular junction disorder. *Guillain-Barré* - **Guillain-Barré syndrome (GBS)** is an **acute demyelinating polyneuropathy** characterized by ascending paralysis and areflexia, usually following an infection. - EMG in GBS typically shows signs of **demyelination** (e.g., prolonged distal latencies, slowed conduction velocities, conduction block), rather than a decremental response at the neuromuscular junction.
Question 8: 21-year-old female presents with history of mild bilateral ptosis, proximal muscle weakness, and easy fatiguability. Which among the following is best in diagnosing this condition?
- A. Muscle biopsy
- B. Edrophonium test (Correct Answer)
- C. Repetitive nerve stimulation
- D. Electromyography
Explanation: The patient's symptoms of **mild bilateral ptosis**, **proximal muscle weakness**, and **easy fatigability** are highly suggestive of **myasthenia gravis**. [1] The **edrophonium (Tensilon) test** involves administering a short-acting acetylcholinesterase inhibitor, which temporarily improves muscle weakness in patients with myasthenia gravis, confirming the diagnosis. While muscle biopsy is helpful in diagnosing certain myopathies, it is **not the primary diagnostic test for myasthenia gravis**. Myasthenia gravis is a **neuromuscular junction disorder**, and muscle pathology is typically normal or non-specific. This neurophysiological study is indeed a valuable tool for diagnosing myasthenia gravis, showing a **decrement in muscle action potential amplitude** with repetitive stimulation. However, the **edrophonium test** is often a quicker and more direct initial diagnostic test due to its rapid and dramatic symptomatic improvement. **Electromyography (EMG)** can help differentiate between neuropathic and myopathic conditions and identify abnormalities in muscle activity. While single-fiber EMG is highly sensitive for myasthenia gravis [2], standard needle EMG is **not the most specific or definitive test** compared to the edrophonium test.
Question 9: The electromyogram (EMG) is least useful for the diagnosis of:
- A. Myasthenia gravis
- B. Charcot-Marie-Tooth disease
- C. Spinal muscular atrophy
- D. Cerebral palsy (Correct Answer)
Explanation: ***Cerebral palsy*** - Cerebral palsy is a **disorder of movement and posture** caused by non-progressive brain damage, primarily affecting the **upper motor neurons**. - While EMG can assess muscle activity, its primary role is in evaluating **lower motor neuron diseases** and **neuromuscular junction disorders**, making it less directly useful for diagnosing a central nervous system disorder like cerebral palsy. *Myasthenia gravis* - EMG, particularly **repetitive nerve stimulation**, is highly useful for diagnosing myasthenia gravis by revealing a **decremental response** in the compound muscle action potential due to impaired neuromuscular transmission [1]. - It directly assesses the function of the **neuromuscular junction**, which is the site of pathology in myasthenia gravis [1]. *Charcot-Marie-Tooth disease* - EMG and **nerve conduction studies (NCS)** are crucial for diagnosing Charcot-Marie-Tooth disease by demonstrating **abnormal nerve conduction velocities** (demyelinating forms) or **reduced amplitude** of compound muscle action potentials (axonal forms) which indicate peripheral nerve damage. - The findings help characterize the type and severity of **peripheral neuropathy**, a hallmark of this condition. *Spinal muscular atrophy* - EMG is essential for diagnosing spinal muscular atrophy by showing **denervation and reinnervation changes** in muscles, such as **fibrillations**, **positive sharp waves**, and **large-amplitude, long-duration motor unit potentials** [1]. - These findings reflect the loss of **anterior horn cells** and subsequent attempts by surviving motor neurons to reinnervate muscle fibers.
Question 10: Cobra poison is:
- A. Vasculotoxic
- B. Myotoxic
- C. Neurotoxic (Correct Answer)
- D. Cardiotoxic
Explanation: ***Neurotoxic*** - Cobra venom contains **alpha-neurotoxins** that block **nicotinic acetylcholine receptors** at neuromuscular junctions, causing flaccid paralysis. - The primary cause of death is **respiratory failure** due to paralysis of respiratory muscles, making neurotoxicity the dominant mechanism. *Vasculotoxic* - Vasculotoxic effects are characteristic of **viper venoms**, causing bleeding, swelling, and tissue necrosis. - Cobra venom's primary action targets the **nervous system**, not blood vessels. *Myotoxic* - Myotoxic venoms directly damage **muscle tissue**, leading to rhabdomyolysis and muscle pain. - While minor muscle effects may occur, **neurotoxicity** remains the predominant and life-threatening mechanism in cobra envenomation. *Cardiotoxic* - Some cobra venoms contain **cardiotoxins**, but these are secondary to the primary neurotoxic effects. - The main cause of cardiovascular collapse is **respiratory paralysis**, not direct cardiac toxicity.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free